PCSK9, Human (Bococizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-PCSK9, Human (Bococizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPCSK9, Human (Bococizumab biosimilar)
CloneBococizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFCM, IP, ELISA, Neut, FuncS
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human PCSK9 Recombinant Antibody (Bococizumab). Bococizumab (USAN, development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the drug from development in November 2016, determining that it was "not likely to provide value to patients, physicians or shareholders."
Immunogenn/a
Other NamesAnti-PCSK9 Recombinant Antibody, Research Grade Bococizumab, Anti-Human PCSK9 Recombinant Antibody(Bococizumab), PF-04950615, RN-316, Antibody Drug Analogues, Monoclonal Antibody, YR1327, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1407495-02-6
Catalog #YR1327
Priceplease inquire
Order / More InfoPCSK9, Human (Bococizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.